C07D 225/06
Condensed with one six-membered ring
Official title: condensed with one six-membered ring
C07D225/06 (Condensed with one six-membered ring) appears on 113 US grants and 97 published applications in this corpus.
Search patents in C07D- Granted patents
- 113
- Published applications
- 97
- Assignees
- 65
- Inventors
- 329
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 3 |
| 2003 | 2 | 3 |
| 2004 | 1 | 4 |
| 2005 | 7 | 11 |
| 2006 | 4 | 6 |
| 2007 | 5 | 4 |
| 2008 | 5 | 6 |
| 2009 | 5 | 17 |
| 2010 | 9 | 5 |
| 2011 | 2 | 7 |
| 2012 | 3 | 4 |
| 2013 | 5 | 2 |
| 2014 | 2 | 2 |
| 2015 | 2 | 2 |
| 2016 | 1 | 4 |
| 2017 | 1 | 0 |
| 2018 | 3 | 2 |
| 2019 | 1 | 3 |
| 2020 | 1 | 5 |
| 2021 | 1 | 2 |
| 2022 | 2 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Benzonitric heterocyclic compound, preparation method therefor and use thereof18 Aug 2026US 12,709,600 B2Shanghai Institute of Pharmaceutical Industry
- Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors to reduce detrimental effects of perfusion deficiency of parenchymal organs24 Jun 2025US 12,337,001 B2
- P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof3 Dec 2024US 12,157,726 B2Shanghai Zhimeng Biopharma, Inc.
- Method for producing optically active substance, optically active substance, method for producing chiral molecule, and chiral molecule14 Mar 2023US 11,603,337 B2Daicel Corporation
- P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof21 Jun 2022US 11,365,181 B2Shanghai Zhimeng Biopharma, Inc.
- Reblastatin derivative and its use in nervous system diseases28 May 2026US 2026/0146027 A1Chinese Academy of Medical Sciences, Institute of Basic Medical Sciences
- Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors to reduce detrimental effects of perfusion deficiency of parenchymal organs9 Oct 2025US 2025/0312354 A1
- Substituted hetero-bicyclocompounds as subtype selective nicotinic acetylcholine receptor inhibitors25 Jul 2024US 2024/0246970 A1
- Benzonitric heterocyclic compound, preparation method therefor and use thereof25 May 2023US 2023/0159463 A1Shanghai Institute of Pharmaceutical Industry
- P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof21 Jul 2022US 2022/0227721 A1Shanghai Zhimeng Biopharma, Inc.
Most cited
By later US patents
- Geldanamycin derivatives and antitumor drug89US 4,261,989 AKaken Chemical Co., Ltd. · 1981
- Methods and compositions for destruction of selected proteins74US 6,670,348 B1Sloan-Kettering Institute for Cancer Research · 2003
- Condensed heterocyclic ketone derivatives and their use51US 5,462,934 ATakeda Chemical Industries, Ltd. · 1995
- Benzoheterocyclic compounds46US 5,559,230 AOtsuka Pharmaceutical Co., Ltd. · 1996
- Benzoquinone ansamycins46US 6,872,715 B2Kosan Biosciences, Inc. · 2005